Shuang He
State Key Laboratory Of Component Based Chinese Medicine, Beihua South Road
Jinghai, 301617, China
Jinghai, 301617, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Corrigendum to "Protection of Stroke-induced Blood-Brain Barrier Disruption by Guanxinning Injection and Its Active-component Combination via TLR4/NF-κB/MMP9-mediated Neuroinflammation" [Phytomedicine. 2025 Nov; 147:157162].
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: June 26, 2026
Senkyunolide I and Danshensu in combination ameliorate post-MI myocardial fibrosis by regulating TGF-β1/PAI-1 in mice and heart organoids.
Journal: Frontiers in pharmacology
Published: April 22, 2026
Gut microbiota in blood pressure control: Friend or foe?
Journal: Microbiological research
Published: April 17, 2026
Microbial metabolites: Bridging the gut-brain divide in ischemic stroke.
Journal: Microbiological research
Published: November 13, 2025
Identification of salvianolic acid A as an ADP receptor-selective and Gq/IP3 pathway-mediated anti-platelet component in Qishen Yiqi.
Journal: Chinese medicine
Published: April 27, 2025
Protection against stroke-induced blood-brain barrier disruption by Guanxinning injection and its active-component combination via TLR4/NF-κB/MMP9-mediated neuroinflammation.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 20, 2025
Isoquercitrin Promotes Angiogenesis Through the Genomic Signaling Pathway of the Estrogen Receptor-Alpha.
Journal: Phytotherapy research : PTR
Published: February 19, 2025
Traditional Mongolian medicine Wu-Lan thirteen-flavor decoction protects rat from hypertension-induced renal injury via aryl hydrocarbon receptor-mediated pathway.
Journal: Drug development and industrial pharmacy
Published: November 20, 2024
Qishen Yiqi alleviates periostin-mediated cardiac fibrosis and hypertrophy in Dahl hypertensive rat hearts and angiotensin II-induced cardiac organoids.
Journal: Frontiers in pharmacology
Published: September 05, 2024
Heart-brain interaction in cardiogenic dementia: pathophysiology and therapeutic potential.
Journal: Frontiers in cardiovascular medicine
Published: October 07, 2023
Last Updated: 09/26/2026